{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:10:26Z","timestamp":1767856226392,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea National Institute of Health (KR)","award":["NIH 4800-4845-300"],"award-info":[{"award-number":["NIH 4800-4845-300"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178259","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T17:44:11Z","timestamp":1495647851000},"page":"e0178259","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice"],"prefix":"10.1371","volume":"12","author":[{"given":"Hyun Ju","family":"In","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeji","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yeon","family":"Hyeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Gu","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Sik","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ki","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-0134","authenticated-orcid":true,"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"SS Wong","year":"2010","journal-title":"Epidemiology and infection"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3201\/eid0904.020395","article-title":"Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes","volume":"9","author":"MJ Cardosa","year":"2003","journal-title":"Emerging infectious diseases"},{"issue":"16","key":"ref3","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1128\/JVI.75.16.7732-7738.2001","article-title":"Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia","volume":"75","author":"P McMinn","year":"2001","journal-title":"J Virol"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.73.12.9969-9975.1999","article-title":"Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998","volume":"73","author":"BA Brown","year":"1999","journal-title":"J Virol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to Licensure of Enterovirus 71 Vaccines","volume":"6","author":"M-S Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"T Solomon","year":"2010","journal-title":"The Lancet Infectious diseases"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4161\/hv.24949","article-title":"Progress on the research and development of inactivated EV71 whole-virus vaccines","volume":"9","author":"ZL Liang","year":"2013","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/j.vaccine.2010.02.095","article-title":"The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox","volume":"28","author":"E Heinsbroek","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00705-011-1136-3","article-title":"Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71","volume":"157","author":"Q Mao","year":"2012","journal-title":"Archives of Virology"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4161\/hv.21739","article-title":"Production of EV71 vaccine candidates","volume":"8","author":"P Chong","year":"2012","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial","volume":"30","author":"YP Li","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"AH Chou","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/cti.2014.24","article-title":"EV71 vaccine, an invaluable gift for children","volume":"3","author":"Z Liang","year":"2014","journal-title":"Clinical & Translational Immunology"},{"issue":"20","key":"ref14","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the Far East","volume":"28","author":"J Xu","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"M-S Lee","year":"2010","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-012-0237-z","article-title":"Progress on the research and development of human enterovirus 71 (EV71) vaccines","volume":"7","author":"Z Liang","year":"2012","journal-title":"Frontiers of Medicine"},{"issue":"9882","key":"ref17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"FC Zhu","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"1579","key":"ref18","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1098\/rstb.2011.0075","article-title":"Twenty-first century vaccines. Philosophical Transactions of the Royal Society B","volume":"366","author":"R Rappuoli","year":"2011","journal-title":"Biological Sciences"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"P Marrack","year":"2009","journal-title":"Nature reviews Immunology"},{"issue":"24","key":"ref20","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1016\/j.vaccine.2007.12.002","article-title":"Lipid A and liposomes containing lipid A as antigens and adjuvants","volume":"26","author":"CR Alving","year":"2008","journal-title":"Vaccine"},{"issue":"5831","key":"ref21","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"V Mata-Haro","year":"2007","journal-title":"Science"},{"issue":"4","key":"ref22","first-page":"R759","article-title":"The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism","volume":"287","author":"ME Fortier","year":"2004","journal-title":"American journal of physiology Regulatory"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Z Ku","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3345\/kjp.2010.53.5.616","article-title":"Enterovirus 71 infection: An experience in Korea, 2009","volume":"53","author":"KH Kim","year":"2010","journal-title":"Korean J Pediatr"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3201\/eid1611.100104","article-title":"Enterovirus 71 Infection with Central Nervous System Involvement","volume":"16","author":"R Wi-Sun","year":"2010","journal-title":"South Korea. Emerging Infectious Disease journal"},{"issue":"Supplement 3","key":"ref26","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1086\/313883","article-title":"Improving Vaccine Performance with Adjuvants","volume":"30","author":"FR Vogel","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"ref27","article-title":"Human enterovirus 71 epidemics: what's next?","volume":"6","author":"CCY Yip","year":"2013","journal-title":"Emerging Health Threats Journal"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2010.04.004","article-title":"New adjuvants for human vaccines","volume":"22","author":"ML Mbow","year":"2010","journal-title":"Current opinion in immunology"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ygyno.2008.05.036","article-title":"Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16\/18 vaccine: improving upon nature","volume":"110","author":"TF Schwarz","year":"2008","journal-title":"Gynecologic oncology"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"AM Didierlaurent","year":"2014","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"N Garcon","year":"2011","journal-title":"Expert review of vaccines"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2334-13-348","article-title":"Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial","volume":"13","author":"HC Rumke","year":"2013","journal-title":"BMC infectious diseases"},{"issue":"43","key":"ref33","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1016\/j.vaccine.2014.08.029","article-title":"Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines","volume":"32","author":"J Ann","year":"2014","journal-title":"Vaccine"},{"issue":"14","key":"ref34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2013.10.081","article-title":"HPV vaccines to prevent cervical cancer and genital warts: an update","volume":"32","author":"C Dochez","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/JVI.01779-10","article-title":"Sustained High Levels of Interleukin-6 Contribute to the Pathogenesis of Enterovirus 71 in a Neonate Mouse Model","volume":"85","author":"WX Khong","year":"2011","journal-title":"Journal of Virology"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/345905","article-title":"Proinflammatory Cytokine Reactions in Enterovirus 71 Infections of the Central Nervous System","volume":"36","author":"T-Y Lin","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/376998","article-title":"Pathogenesis of Enterovirus 71 Brainstem Encephalitis in Pediatric Patients: Roles of Cytokines and Cellular Immune Activation in Patients with Pulmonary Edema","volume":"188","author":"S-M Wang","year":"2003","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo","volume":"25","author":"T Germann","year":"1995","journal-title":"European journal of immunology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease","volume":"84","author":"KC Ong","year":"2010","journal-title":"Journal of Virology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T12:04:49Z","timestamp":1602158689000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178259"}},"subtitle":[],"editor":[{"given":"Ralph","family":"Tripp","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178259","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,24]]}}}